Director, Center for Healthy Aging Research
Associate Professor and Chief of Cognitive Neurology
Rutgers-RWJ Medical School
Institute for Health, Health Care Policy, and Aging Research
Rutgers Biomedical and Health Sciences
Dr. Hu is a board-certified neurologist and NIH-funded neuroscientist with expertise in Alzheimer’s disease, frontotemporal dementia, Lewy body dementia, and long COVID. He directs the Division of Cognitive Neurology and Alzheimer’s Disease Clinic at Robert Wood Johnson Medical School, as well as the Center for Healthy Aging Research at Rutgers Institute for Health. He completed his training at the Mayo Clinic and University of Pennsylvania, and brings over 20 years of experience in clinical and translational neuroscience to Rutgers.
Dr. Hu conducts research in biomarkers related to Alzheimer’s disease, frontotemporal dementia, and long COVID. He was the first to provide the staging scheme for a common pathology in Alzheimer’s disease; develop a reliable diagnostic test for FTD due to TDP-43; show that Black and White Americans have different cerebrospinal fluid profiles of Alzheimer’s disease and inflammation; and identify clinical & biochemical profiles for cognitive impairment (aka “brain fog”) in long COVID using longitudinal tracking and highly innovative gene profiling. As a physician-scientist, he leads the Rutgers Biomarkers of Neurodegeneration Project, Rutgers South Asian Aging Brain Initiative, Rutgers-Stanford Chinese Older Adult Study, Rutgers-NYU Resource Center for Alzheimer’s and Dementia Research in Asian and Pacific Americans, and the Cognition/Biomarker component of the New Jersey Population Health Cohort Study.